Clinical trial approval / initiation

Explore the landscape of Clinical trial approval / initiation in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on Clinical trial approval / initiation to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

ArkBio Publishes Pivotal Phase 3 Data for Azstarys in Chinese Children with ADHD – NMPA‑Approved Dual‑Release Formulation Nears Commercial Launch
CompanyDrug

ArkBio Publishes Pivotal Phase 3 Data for Azstarys in Chinese Children with ADHD – NMPA‑Approved Dual‑Release Formulation Nears Commercial Launch

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") announced that results from the pivotal Phase 3 trial of Azstarys™ (serdexmethylphenidate chloride and dexmethylphenidate hydrochloride capsules) in Chinese children aged 6–12 years with…

GenFleet's Oral KRAS G12D Inhibitor GFH375/VS‑7375 Delivers Positive Data Across Global Studies – World's First KRAS G12D Agent in Phase III for NSCLC and Pancreatic Cancer

GenFleet’s Oral KRAS G12D Inhibitor GFH375/VS‑7375 Delivers Positive Data Across Global Studies – World’s First KRAS G12D Agent in Phase III for NSCLC and Pancreatic Cancer

Centergate Technologies Subsidiary Duoduo Pharmaceutical Has Calcium Dobesilate Capsules Application Accepted by NMPA – Generic Filing Enters Review for Established Capillary Protectant

Centergate Technologies Subsidiary Duoduo Pharmaceutical Has Calcium Dobesilate Capsules Application Accepted by NMPA – Generic Filing Enters Review for Established Capillary Protectant

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Simcere Completes Enrollment for Phase III Study of CDK4/6 Inhibitor in mTNBC

CompanyDrug

Fujian Cosunter Doses First Patient in Phase I Study of COVID-19 Drug GST-HG171

CompanyDrug

Ascletis Pharma Doses First Patient in Phase II Study of ASC41 for NASH

CompanyDrug

Transcenta’s TST004 Receives FDA IND Clearance for IgAN Treatment

CompanyDrug

Kira Pharmaceuticals Gets FDA Green Light for Phase II Study of KP104 in SLE-TMA

CompanyDrug

Staidson’s STSP-0601 Receives Clinical Trial Approval for Hemophilia Treatment

CompanyDrug

Henlius Biotech Gets FDA Nod for HLX07 Clinical Study in CSCC

CompanyDrug

Neurophth Biotechnology Doses First Patient in Phase III Trial for NR082

Show More